Dr. Malisa Agard, MD
Claim this profileConquest Research
Studies Alzheimer's Disease
Studies Dementia
12 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Malisa Agard, MD is currently running
Remternetug
for Alzheimer's Disease
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo. Participation could last up to 255 weeks including screening, a double-blind treatment period, and a double-blind observation period. In addition, eligible participants who receive placebo during the double-blind treatment period may choose to extend their study participation to receive open-label remternetug in an extension period.
Recruiting1 award Phase 31 criteria
PMN310
for Alzheimer's Disease
This Phase 1b study aims to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of multiple IV infusions of PMN310 in patients with early Alzheimer's disease.
Recruiting0 awards Phase 12 criteria
More about Malisa Agard, MD
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Malisa Agard, MD has experience with
- Placebo
- Buntanetap
- SB-01 For Injection
- Sham Needle
- Clonidine Micropellets
- Tuohy Epidural Needle
Breakdown of trials Malisa Agard, MD has run
Alzheimer's Disease
- Donanemab for Early Alzheimer's Disease
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- BIIB080 for Alzheimer's Disease
Dementia
Mild Cognitive Impairment
Spinal Diseases
Degenerative Disc Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Malisa Agard, MD specialize in?
Malisa Agard, MD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Malisa Agard, MD currently recruiting for clinical trials?
Yes, Malisa Agard, MD is currently recruiting for 2 clinical trials in Winter Park Florida. If you're interested in participating, you should apply.
Are there any treatments that Malisa Agard, MD has studied deeply?
Yes, Malisa Agard, MD has studied treatments such as Placebo, Buntanetap, SB-01 For Injection.
What is the best way to schedule an appointment with Malisa Agard, MD?
Apply for one of the trials that Malisa Agard, MD is conducting.
What is the office address of Malisa Agard, MD?
The office of Malisa Agard, MD is located at: Conquest Research, Winter Park, Florida 32789 United States. This is the address for their practice at the Conquest Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.